Gene · 6607
Papers3,510
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,141 to 1,160 of 3,510
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Organotypic spinal cord cultures: An <em>in vitro</em> 3D model to preliminary screen treatments for spinal muscular atrophy. | Eur J Histochem | 2021 | 34734684 | PubTator, text mining | PubMed |
| Recombinant Adeno-Associated Virus Serotype 9 Gene Therapy in Spinal Muscular Atrophy. | Front Neurol | 2021 | 34721262 | PubTator, text mining | PubMed |
| Analysis of Genotype-Phenotype Correlations in Patients With Degenerative Dementia Through the Whole Exome Sequencing. | Front Aging Neurosci | 2021 | 34720994 | PubTator, text mining | PubMed |
| Single Nucleotide Resolution RNA-Protein Cross-Linking Mass Spectrometry: A Simple Extension of the CLIR-MS Workflow. | Anal Chem | 2021 | 34714631 | PubTator, text mining | PubMed |
| Nusinersen for Spinal Muscular Atrophy in the United States: Findings From a Retrospective Claims Database Analysis. | Adv Ther | 2021 | 34713391 | PubTator, text mining | PubMed |
| Correction: Furnier et al. Translating Molecular Technologies into Routine Newborn Screening Practice. Int. J. Neonatal Screen. 2020, 6, 80. | Int J Neonatal Screen | 2021 | 34698052 | PubTator, text mining | PubMed |
| Correction to: Neurodegenerative diseases: a hotbed for splicing defects and the potential therapies. | Transl Neurodegener | 2021 | 34696812 | PubTator, text mining | PubMed |
| Health Technology Assessment of Advanced Therapy Medicinal Products: Comparison Among 3 European Countries. | Front Pharmacol | 2021 | 34690785 | PubTator, text mining | PubMed |
| Current and Future Prospects for Gene Therapy for Rare Genetic Diseases Affecting the Brain and Spinal Cord. | Front Mol Neurosci | 2021 | 34690692 | PubTator, text mining | PubMed |
| Detection of Spinal Muscular Atrophy Patients Using Dried Saliva Spots. | Genes (Basel) | 2021 | 34681015 | PubTator, text mining | PubMed |
| (In)Distinctive Role of Long Non-Coding RNAs in Common and Rare Ovarian Cancers. | Cancers (Basel) | 2021 | 34680193 | PubTator, text mining | PubMed |
| Alternative Pre-mRNA Splicing of the Mu Opioid Receptor Gene, OPRM1: Insight into Complex Mu Opioid Actions. | Biomolecules | 2021 | 34680158 | PubTator, text mining | PubMed |
| Coordination of RNA Processing Regulation by Signal Transduction Pathways. | Biomolecules | 2021 | 34680108 | PubTator, text mining | PubMed |
| 1H-NMR-based metabolic profiling identifies non-invasive diagnostic and predictive urinary fingerprints in 5q spinal muscular atrophy. | Orphanet J Rare Dis | 2021 | 34670613 | PubTator, text mining | PubMed |
| DNA copy number variation: Main characteristics, evolutionary significance, and pathological aspects. | Biomed J | 2021 | 34649833 | PubTator, text mining | PubMed |
| Motor function in type 2 and 3 SMA patients treated with Nusinersen: a critical review and meta-analysis. | Orphanet J Rare Dis | 2021 | 34645478 | PubTator, text mining | PubMed |
| Regulation of Survival Motor Neuron Gene Expression by Calcium Signaling. | Int J Mol Sci | 2021 | 34638572 | PubTator, text mining | PubMed |
| Nucleic Acid Drugs-Current Status, Issues, and Expectations for Exosomes. | Cancers (Basel) | 2021 | 34638486 | PubTator, text mining | PubMed |
| Systematic Construction and Validation of an RNA-Binding Protein-Associated Prognostic Model for Acute Myeloid Leukemia. | Front Genet | 2021 | 34630514 | PubTator, text mining | PubMed |
| Three years pilot of spinal muscular atrophy newborn screening turned into official program in Southern Belgium. | Sci Rep | 2021 | 34620959 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6607/papers?page=58